Kintara Therapeutics, Inc.
KTRA
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.56% | -96.58% | 65.46% | 11.18% | -2.18% |
| Total Depreciation and Amortization | 112.50% | -46.67% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.27% | -1.86% | 3.37% | -84.69% | -15.75% |
| Change in Net Operating Assets | 237.99% | 61.63% | -193.11% | 213.91% | 337.17% |
| Cash from Operations | 37.30% | -8.64% | -60.74% | 12.67% | 17.46% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 209.76% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 209.93% | 129,050.00% | 0.00% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.33% | 1,188.01% | 133.51% | 12.65% | 17.44% |
